Richard Christopher
2020 - InVivo Therapeutics Holdings
In 2020, Richard Christopher earned a total compensation of $558.3K as Chief Financial Officer at InVivo Therapeutics Holdings, a 18% decrease compared to previous year.
Compensation breakdown
| Bonus | $196,768 |
|---|---|
| Salary | $343,200 |
| Other | $18,375 |
| Total | $558,343 |
Christopher received $343.2K in salary, accounting for 61% of the total pay in 2020.
Christopher also received $196.8K in bonus and $18.4K in other compensation.
Rankings
In 2020, Richard Christopher's compensation ranked 10,708th out of 13,090 executives tracked by ExecPay. In other words, Christopher earned more than 18.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,708 out of 13,090 | 18th |
Division Manufacturing | 4,580 out of 5,620 | 19th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 602 out of 799 | 25th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 375 out of 495 | 24th |
Industry Surgical and Medical Instruments and Apparatus | 244 out of 313 | 22nd |
Source: SEC filing on May 18, 2021.
Christopher's colleagues
We found one more compensation record of an executive who worked with Richard Christopher at InVivo Therapeutics Holdings in 2020.
2020
Richard Toselli
InVivo Therapeutics Holdings
Chief Executive Officer
News
InVivo Therapeutics Holdings CEO Richard Toselli's 2022 pay slips 11% to $960K
December 5, 2023
InVivo Therapeutics Holdings CEO Richard Toselli's 2021 pay jumps 30% to $1.1M
August 18, 2022
InVivo Therapeutics Holdings CEO Richard Toselli's 2020 pay falls 34% to $832K
May 18, 2021
InVivo Therapeutics Holdings CEO Richard Toselli's 2019 pay jumps 69% to $1.3M
June 22, 2020